Venetoclax plus rituximab in relapsed chronic lymphocytic leukemia: 4-year results and evaluation of impact of genomic complexity and gene mutations from the MURANO phase III study

1. Kater, A.P.
2. Wu, J.Q.
3. Kipps, T.
4. Eichhorst, B.
5. Hillmen, P.
6. D'Rozario, J.
7. Assouline, S.
8. Owen, C.
9. Robak, T.
10. de la Serna, J.
11. Jaeger, U.
12. Cartron, G.
13. Montillo, M.
14. Dubois, J.
15. Eldering, E.
16. Mellink, C.
17. van der Kevie-Kersemaekers, A.-M.
18. Kim, S.Y.
19. Chyla, B.
20. Punnoose, E.
21. Bolen, C.R.
22. Assaf, Z.J.
23. Jiang, Y.
24. Wang, J.
25. Lefebure, M.
26. Boyer, M.
27. Humphrey, K.
28. Seymour, J.F.
29. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1200/JCO.20.00948 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus